Bexitrol F Inhaler (25 mcg + 250 mcg)/puff is a combination inhalation therapy containing Salmeterol, a long-acting beta-2 adrenergic agonist, and Fluticasone Propionate, a potent inhaled corticosteroid. This formulation is designed for the regular maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), where both long-term bronchodilation and control of airway inflammation are essential.

The inhaler delivers a metered dose with each puff, ensuring consistent and accurate delivery of medication directly to the lungs. By targeting the airways locally, Bexitrol F Inhaler helps improve breathing, reduce symptom frequency, and prevent disease exacerbations, while minimizing systemic side effects. It is intended for regular use and is not suitable for the immediate relief of acute asthma attacks.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Long-acting beta-2 agonist (LABA) + Inhaled corticosteroid (ICS)

Indications

Bexitrol F Inhaler (25 mcg + 250 mcg)/puff is indicated for:

• Maintenance treatment of bronchial asthma in patients inadequately controlled on inhaled corticosteroids alone

• Long-term management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

• Prevention of asthma symptoms such as wheezing, shortness of breath, chest tightness, and nocturnal symptoms

This strength is suitable for patients who require combination therapy with a moderate dose of inhaled corticosteroid for effective disease control.

Pharmacology

Salmeterol is a selective long-acting beta-2 adrenergic receptor agonist. It relaxes bronchial smooth muscles, producing sustained bronchodilation that lasts for up to 12 hours. This helps keep the airways open and reduces bronchospasm, improving airflow throughout the day and night.

Fluticasone Propionate is a synthetic inhaled corticosteroid with strong anti-inflammatory activity. It works by inhibiting the release of inflammatory mediators, reducing airway swelling, mucus production, and inflammatory cell infiltration. Regular use helps decrease airway hyper-responsiveness and lowers the frequency of asthma exacerbations.

The combination of these two agents provides complementary and synergistic effects, offering superior symptom control compared to either component alone.

Dosage and Administration

Bexitrol F Inhaler is for inhalation use only.

• The usual recommended dose is one puff twice daily or as prescribed by a physician

• The inhaler should be used regularly at the same times each day

• Patients should rinse their mouth with water after inhalation and spit it out to reduce the risk of oral fungal infections

Proper inhaler technique is essential to achieve optimal therapeutic benefit.

Contraindications

Bexitrol F Inhaler is contraindicated in:

• Patients with known hypersensitivity to Salmeterol, Fluticasone Propionate, or any component of the formulation

• Acute asthma attacks or status asthmaticus requiring rapid-acting bronchodilators

Side Effects

Possible side effects may include:

• Throat irritation or hoarseness

• Headache

• Cough

• Oral candidiasis

• Tremor or palpitations (uncommon)

Most adverse effects are mild and reversible with correct use.

Precautions and Warnings

• Not intended for immediate relief of acute bronchospasm

• Use with caution in patients with cardiovascular disease, diabetes mellitus, or thyroid disorders

• Do not discontinue treatment abruptly without medical advice

• Long-term use requires periodic medical monitoring

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Pregnancy and Lactation

Bexitrol F Inhaler should be used during pregnancy and lactation only if the potential benefit justifies the potential risk, and under medical supervision.

Storage Conditions

Store below 30°C in a cool, dry place. Protect from direct sunlight. Keep out of reach of children.

Conclusion

Bexitrol F Inhaler (25 mcg + 250 mcg)/puff is an effective maintenance therapy for asthma and COPD that combines prolonged bronchodilation with reliable anti-inflammatory action. Regular use helps maintain symptom control, reduces exacerbations, and improves overall respiratory health.